↓ Skip to main content

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Overview of attention for article published in The Lancet, September 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#11 of 35,318)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
245 Mendeley
Title
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Published in
The Lancet, September 2020
DOI 10.1016/s0140-6736(20)31866-3
Pubmed ID
Authors

Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatullin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, Daria M Grousova, Alina S Erokhova, Anna V Kovyrshina, Andrei G Botikov, Fatima M Izhaeva, Olga Popova, Tatiana A Ozharovskaya, Ilias B Esmagambetov, Irina A Favorskaya, Denis I Zrelkin, Daria V Voronina, Dmitry N Shcherbinin, Alexander S Semikhin, Yana V Simakova, Elizaveta A Tokarskaya, Nadezhda L Lubenets, Daria A Egorova, Maksim M Shmarov, Natalia A Nikitenko, Lola F Morozova, Elena A Smolyarchuk, Evgeny V Kryukov, Vladimir F Babira, Sergei V Borisevich, Boris S Naroditsky, Alexander L Gintsburg

Twitter Demographics

The data shown below were collected from the profiles of 9,202 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 245 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 245 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 50 20%
Student > Bachelor 34 14%
Other 26 11%
Student > Ph. D. Student 21 9%
Student > Master 14 6%
Other 54 22%
Unknown 46 19%
Readers by discipline Count As %
Medicine and Dentistry 57 23%
Biochemistry, Genetics and Molecular Biology 40 16%
Immunology and Microbiology 17 7%
Agricultural and Biological Sciences 13 5%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Other 47 19%
Unknown 61 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 8904. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2020.
All research outputs
#84
of 16,060,310 outputs
Outputs from The Lancet
#11
of 35,318 outputs
Outputs of similar age
#17
of 292,210 outputs
Outputs of similar age from The Lancet
#4
of 388 outputs
Altmetric has tracked 16,060,310 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 35,318 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 49.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,210 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 388 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.